Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer

Applied Physiology, Nutrition and Metabolism - Tập 33 Số 6 - Trang 1269-1283 - 2008
Rob M. van Dam1
1Department of Nutrition, Harvard School of Public Health; and Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MA 02115, USA (e-mail: ).

Tóm tắt

Numerous epidemiological studies have evaluated the association between coffee consumption and risk of type 2 diabetes, coronary heart disease, and various cancers. This paper briefly reviews the evidence for a relation between coffee consumption and these conditions, with particular attention to methodological issues. Several early studies suggested that coffee consumption could result in a marked increase in risk of coronary heart disease and several types of cancer. However, more recent prospective cohort studies that are less prone to selection and information bias have not confirmed these findings. High consumption of unfiltered types of coffee, such as French press and boiled coffee, has been shown to increase low-density-lipoprotein-cholesterol concentrations. In addition, limiting caffeinated coffee intake during pregnancy seems a prudent choice. However, evidence has been accumulating that frequent consumption of coffee may reduce risk of type 2 diabetes and liver cancer. Further experimental studies are warranted to elucidate the underlying mechanisms and possibly identify the components in coffee that are responsible for these putative effects. In sum, the currently available evidence on coffee and risk of cardiovascular diseases and cancer is largely reassuring, and suggests that, for the general population, addressing other health-related behaviors has priority for the prevention of chronic diseases.

Từ khóa


Tài liệu tham khảo

Andersen L.F., 2006, Am. J. Clin. Nutr., 83, 1039, 10.1093/ajcn/83.5.1039

10.1016/S0378-8741(01)00335-X

Battram D.S., 2006, J. Nutr., 136, 1276, 10.1093/jn/136.5.1276

Baylin A., 2006, Epidemiology, 17, 506, 10.1097/01.ede.0000229444.55718.96

10.1093/aje/kwi317

10.1007/BF01061844

Botelho F., 2006, Cad. Saude Publica, 22, 889, 10.1590/S0102-311X2006000500002

10.1097/00001648-200203000-00011

10.1002/hep.21708

10.1093/ije/dyh185

10.1021/jf990702b

10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D

10.1001/jama.295.10.1135

Čulić V., 2007, Epidemiology, 18, 282, 10.1097/01.ede.0000254655.36084.c5

10.1093/aje/154.2.150

10.1016/S0014-2999(02)01540-6

Dlugosz L., 1992, Epidemiol. Rev., 14, 83, 10.1093/oxfordjournals.epirev.a036093

Egger M., 1998, BMJ, 316, 61, 10.1136/bmj.316.7124.61

10.1016/0002-8223(93)91754-E

10.1002/ijc.23336

Giovannucci E., 1998, Am. J. Epidemiol., 147, 1043, 10.1093/oxfordjournals.aje.a009398

10.1038/sj.ijo.0802999

Greenberg J.A., 2007, Am. J. Clin. Nutr., 85, 392, 10.1093/ajcn/85.2.392

Greenland S., 1993, Epidemiology, 4, 366, 10.1097/00001648-199307000-00013

10.2337/diabetes.50.10.2349

Grobbee D.E., 1990, N. Engl. J. Med., 323, 1026, 10.1056/NEJM199010113231504

10.1016/S0895-4356(98)00023-7

Hamer M., 2008, Br J Nutr.

10.1093/ije/25.2.235

Hu G., 2007, Am. J. Clin. Nutr., 86, 457, 10.1093/ajcn/86.2.457

Inoue M., 2005, J. Natl. Cancer Inst., 97, 293, 10.1093/jnci/dji040

Iso H., 2006, Ann. Intern. Med., 144, 554, 10.7326/0003-4819-144-8-200604180-00005

10.1079/BJN20051522

10.1093/aje/153.4.353

10.1136/hrt.72.3.269

10.2337/diacare.25.2.364

10.1001/archinte.162.6.657

10.1001/archinte.166.11.1190

10.1038/sj.bjc.6602737

10.1016/j.jhep.2005.01.004

10.2337/diacare.27.8.2047

Lane J.D., 2007, Endocr. Pract., 13, 239, 10.4158/EP.13.3.239

10.2337/dc07-1112

10.1053/j.gastro.2007.03.044

10.1093/aje/kwj067

Larsson S.C., 2008, Stroke, 39, 1681, 10.1161/STROKEAHA.107.504183

10.1002/ijc.22909

10.1161/CIRCULATIONAHA.105.598664

10.1016/j.metabol.2007.07.013

MacMahon B., 1981, N. Engl. J. Med., 304, 630, 10.1056/NEJM198103123041102

10.1016/j.cdp.2005.06.008

10.1079/BJN20061808

Michaud D.S., 2001, Cancer Epidemiol. Biomarkers Prev., 10, 429

Michels K.B., 2005, J. Natl. Cancer Inst., 97, 282, 10.1093/jnci/dji039

10.1002/ijc.22505

10.1097/01.hjh.0000166828.94699.1d

Olthof M.R., 2001, Am. J. Clin. Nutr., 73, 532, 10.1093/ajcn/73.3.532

10.1093/aje/kwj323

10.1001/archinte.166.12.1311

10.1007/BF01830266

Petridou E., 1997, Br. J. Cancer, 76, 1241, 10.1038/bjc.1997.541

10.1097/EDE.0b013e31806466e5

10.1016/S0140-6736(03)12583-4

10.1172/JCI110124

10.1016/S0955-2863(02)00231-0

Rosenberg L., 1981, Am. J. Epidemiol., 113, 646, 10.1093/oxfordjournals.aje.a113143

10.1046/j.1365-2796.2003.01260.x

10.1093/aje/kwk013

10.1002/(SICI)1097-0215(1998)78:11+<26::AID-IJC8>3.0.CO;2-M

10.1053/j.gastro.2004.09.075

Salazar-Martinez E., 2004, Ann. Intern. Med., 140, 1, 10.7326/0003-4819-140-1-200401060-00005

10.1093/ije/18.4.858

10.2337/diacare.26.7.2211

10.1097/EDE.0b013e3181775e23

10.2337/dc06-2089

Šelb Šemerl J., 2004, Croat. Med. J., 45, 775

Shearer J., 2003, J. Nutr., 133, 3529, 10.1093/jn/133.11.3529

10.1139/Y07-070

10.1002/ijc.20989

10.1097/01.ede.0000112221.24237.0c

10.1161/CIRCULATIONAHA.107.712976

10.2337/dc06-1084

10.1016/j.numecd.2006.07.013

10.1097/01.hjh.0000226196.67052.c0

10.1001/jama.291.10.1213

10.1016/S1047-2797(02)00462-3

Uiterwaal C.S., 2007, Am. J. Clin. Nutr., 85, 718, 10.1093/ajcn/85.3.718

10.1021/jf00056a039

Urgert R., 2000, Am. J. Clin. Nutr., 72, 1107, 10.1093/ajcn/72.5.1107

10.1016/S0140-6736(02)11436-X

10.1001/jama.294.1.97

10.1007/s00125-004-1573-6

10.2337/diacare.27.12.2990

10.2337/diacare.29.02.06.dc05-1512

Verhoef P., 2002, Am. J. Clin. Nutr., 76, 1244, 10.1093/ajcn/76.6.1244

10.1080/10641960600798655

Weusten-Van der Wouw M.P., 1994, J. Lipid Res., 35, 721, 10.1016/S0022-2275(20)41169-1

10.3132/dvdr.2007.033

Willett, W.C. 1998. Nutritional epidemiology. Oxford University Press, New York.

10.1001/jama.275.6.458

10.1001/jama.294.18.2330

10.2337/diacare.28.6.1390

10.1093/humrep/dem316

10.1007/s00125-004-1590-5

10.1007/s00345-003-0382-8

10.1016/0140-6736(90)91302-Q